Among these molecular regulators, Fyn, a non-receptor tyrosine kinase, has emerged as a modulator of specific glucolipid metabolism signaling pathways such as AMPK pathways, and several inflammatory signaling pathways, thus being implicated in T2DM pathogenesis. This evidence concerns the gene FYN and type 2 diabetes mellitus.